Financial results: Avecho; Elixinol; Epsilon; Creso Pharma by Steve Jones May 2, 2023April 30, 2024 Biotech firm Avecho has told the Australian Securities Exchange (ASX) that it has no concerns over […]
AusCann remains in holding pattern as proposed acquisition is delayed by Steve Jones May 1, 2023April 30, 2024
Cultivators set for Canberra in bid to accelerate growth of local industry by Steve Jones April 27, 2023April 30, 2024
‘We need to put ourselves out of a job’ – GP duo plan to build national cannabis prescriber network by Steve Jones April 20, 2023April 30, 2024
Streamlined veterans funding process prompts clinic to offer cut-price consultation fees by Steve Jones April 19, 2023April 30, 2024
Clinical trial to study impact of cannabis on endometriosis by Steve Jones April 19, 2023April 30, 2024
Cann Group prepares for ‘quantum step’ but remains shy on positive cash flow timeframe by Steve Jones April 18, 2023April 30, 2024
Exhibitors withdrew from hemp expo amid fears of TGA crackdown by Steve Jones April 13, 2023April 30, 2024
Industry bodies release draft code of conduct to set standards for patient care by Steve Jones and Martin Lane April 13, 2023April 30, 2024
Cannaponics launches crowdfunding push as WA construction ramps up by Steve Jones April 12, 2023April 30, 2024
